Browsing by Subject "Colistin"
Now showing items 1-3 of 3
-
Colistin plus sulbactam or fosfomycin against carbapenem-resistant acinetobacter baumannii: improved efficacy or decreased risk of nephrotoxicity?
Collection: Article - Pharmaceutical Care / บทความ - บริบาลทางเภสัชกรรมType: Article(The Korean Society of Infectious Diseases, Korean Society for Antimicrobial Therapy, and The Korean Society for AIDS, 2021)Background Acinetobacter baumannii has been recognized as a cause of nosocomial infection. To date, polymyxins, the last-resort therapeutic agents for carbapenem-resistant A. baumannii (CRAB). Thus, the small number of ... -
The prevalence of colistin-resistant Gram-negative bacteria isolated from hospitalized patients with bacteremia
Collection: Article - Pharmaceutical Care / บทความ - บริบาลทางเภสัชกรรมType: Article(Open Science Publishers, 2020)This study sought to investigate the prevalence of colistin-resistant Gram-negative bacteria (CoR-GNB) among Pseudomonas aeruginosa, Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae isolated from patients ... -
The Synergistic activity and optimizing doses of tigecycline in combination with aminoglycosides against clinical carbapenem-resistant klebsiella pneumoniae isolates
Collection: Article - Pharmaceutical Care / บทความ - บริบาลทางเภสัชกรรมType: Article(MDPI Open Access journal, 2021)Carbapenem-resistant Enterobacteriaceae (CRE), especially carbapenem-resistant Klebsiella pneumoniae (CRKP), are among the largest pathogenic threats to humans. The available antibiotic treatment options for combating CRKP ...